Takeda signs $1.7bn AI alliance with Iambic Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders

#Takeda #AIalliance #AI #IambicTherapeutics #drugdiscovery #inflammatorydiseases #oncology #NeuralPLexer #smallmoleculetherapeutics #RevolutionMedicines #neurology #Lundbeck #NablaBio #Arzeda #nference #CytoReason #AIStructuralBiology #AISBconsortium #OpenFoldstructure
zurl.co/wMIRf

CytoReason Introduces LINA: The Revolutionary AI Agent in Pharma R&D Powered by NVIDIA CytoReason has announced LINA, an innovative AI agent designed to enhance the pharmaceutical R&D sector by leveraging advanced computational disease models and NVIDIA's ecosystem.

CytoReason Introduces LINA: The Revolutionary AI Agent in Pharma R&D Powered by NVIDIA #Israel #Tel_Aviv #NVIDIA #LĪNA #CytoReason

CytoReason and Sanofi Strengthen Partnership to Enhance AI in Drug Discovery CytoReason has enhanced its collaboration with Sanofi to harness AI for drug discovery, aiming to improve R&D processes and patient insights.

CytoReason and Sanofi Strengthen Partnership to Enhance AI in Drug Discovery #Israel #Tel_Aviv #AI_Drug_Discovery #Sanofi #CytoReason

Backed by Nvidia and #Pfizer, Israeli AI medical startup raises $80m in fresh capital Tel Aviv-based #CytoReason, which uses machine learning to build computational models of human diseases to speed up treatment discoveries, plans to open a US office later this year The post Backed by Nvidia and #Pfizer, Israeli AI medical startup raises…

Backed by Nvidia and #Pfizer, Israeli AI medical startup raises $80m in fresh capital: Tel Aviv-based #CytoReason, which uses machine learning to build computational models of human diseases to speed up treatment discoveries, plans to open a US office later this year


The post Backed by Nvidia and…